Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Am J Pathol ; 191(6): 1020-1035, 2021 06.
Artículo en Inglés | MEDLINE | ID: mdl-33705750

RESUMEN

Glucocorticoid-induced glaucoma is a secondary open-angle glaucoma. About 40% of the general population may develop elevated intraocular pressure on prolonged glucocorticoid treatment secondary to damages in the trabecular meshwork (TM), a tissue that regulates intraocular pressure. Therefore, identifying the key molecules responsible for glucocorticoid-induced ocular hypertension is crucial. In this study, Dickkopf-related protein 1 (Dkk1), a canonical Wnt signaling inhibitor, was found to be elevated in the aqueous humor and TM of glaucoma patients. At the signaling level, Dkk1 enhanced glucocorticoid receptor (GR) signaling, whereas Dkk1 knockdown or Wnt signaling activators decreased GR signaling in human TM cells as indicated by luciferase assays. Similarly, activation of the GR signaling inhibited Wnt signaling. At the protein level, glucocorticoid-induced extracellular matrix was inhibited by Wnt activation using Wnt activators or Dkk1 knockdown in primary human TM cells. In contrast, inhibition of canonical Wnt signaling by ß-catenin knockdown increased glucocorticoid-induced extracellular matrix proteins. At the physiological level, adenovirus-mediated Wnt3a expression decreased glucocorticoid-induced ocular hypertension in mouse eyes. In summary, Wnt and GR signaling inhibit each other in the TM, and canonical Wnt signaling activators may prevent the adverse effect of glucocorticoids in the eye.


Asunto(s)
Glaucoma/metabolismo , Receptores de Glucocorticoides/metabolismo , Malla Trabecular/metabolismo , Vía de Señalización Wnt/fisiología , Animales , Femenino , Glaucoma/inducido químicamente , Glucocorticoides/efectos adversos , Humanos , Inmunosupresores/efectos adversos , Ratones , Ratones Endogámicos C57BL
2.
Ann Am Thorac Soc ; 16(8): 957-966, 2019 08.
Artículo en Inglés | MEDLINE | ID: mdl-31091984

RESUMEN

Ophthalmic disease encountered in the intensive care unit (ICU) has a wide spectrum of prevalence and severity. Prolonged exposure of the cornea is common and preventable. Trauma, glaucoma, infection, vascular disease, and burns are among the potential causes of vision loss. Patients are predisposed to ocular complications by the ICU environment and critical illness itself. Critically ill patients require prioritization of life-sustaining interventions, and less emphasis is placed on ophthalmic disease, leading to missed opportunities for vision-saving intervention. It is therefore imperative for intensivists, nurses, and other providers to have an increased awareness and understanding of the broad range of ocular conditions potentially seen in the ICU.


Asunto(s)
Oftalmopatías/etiología , Unidades de Cuidados Intensivos , Oftalmología , Enfermedades de la Córnea/epidemiología , Enfermedades de la Córnea/etiología , Enfermedades de la Córnea/prevención & control , Enfermedad Crítica , Oftalmopatías/epidemiología , Oftalmopatías/prevención & control , Oftalmopatías/terapia , Infecciones del Ojo/epidemiología , Infecciones del Ojo/etiología , Infecciones del Ojo/prevención & control , Humanos , Enfermedad Iatrogénica , Prevalencia , Pronóstico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA